홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Carbetapentane

HCID 2562
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
77-23-6
표준 SMILES
CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1
InChIKey
CFJMRBQWBDQYMK-UHFFFAOYSA-N
분자식
C20H31NO3
평균 분자량
333.5 g/mol
단동위원소 질량
333.23039385

개요

1-phenyl-1-cyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester is a member of benzenes.

이름 및 식별자

우선 이름
Carbetapentane
IUPAC
2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylate
영어명
Pentoxyverine
분자식
C20H31NO3
분자량
333.46

이름 및 동의어

carbetapentanePentoxyverine77-23-6PentoxiverinPentoxyverinAtussilPentoxiverinaPentoxyverinumSedotussin1-Phenyl-1-cyclopentanecarboxylateUCB 2543DTXSID9022734
이름 더 보기
PENTOXIFYLLINEUrexTuclasePentoxyverine Baseucb2543u.c.b.2543U.C.B. 2543
2-(2-Diethylaminoethoxy)ethyl 1-phenylcyclopentanecarboxylate2-(Diethylaminoethoxy)ethyl 1-phenyl-1-cyclopentanecarboxylate2-(Diethylaminoethoxy)ethyl 1-phenylcyclopentyl-1-carboxylate32C726X12W1-Phenylcyclopentane-1-carboxylic acid diethylaminoethoxyethyl esterEthanol, 2-(2-(diethylamino)ethoxy)-, 1-phenylcyclopentanecarboxylate (ester)DTXCID1027341-Phenylcyclopentanecarboxylic acid 2-(2-diethylaminoethoxy)ethyl ester

데이터베이스 식별자

CAS
77-23-6
PubChem CID
2562
DTXSID
DTXSID9022734
ChEMBL
CHEMBL73234
ChEBI
CHEBI:94484
UNII
32C726X12W
EC Number
201-014-1
Nikkaji
J4.198J

물성

구조 계산 물성

XLogP
3.8
극성 표면적
38.8 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
4
회전 가능 결합 수
11
무거운 원자 수
24
형식 전하
0
복잡도
356

실험 및 물리화학적 성질

Drugs · 2건

Pharmaceuticals

Pharmaceuticals -> Listed in ZINC15

SolubilitySOL IN ETHYL ALC /CITRATE/
Human DrugsPharmaceuticals
Boiling Point165-170 °C @ 0.01 MM OF HG
Melting Point90-95
Collision Cross Section175.5 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]
Other Experimental PropertiesCRYSTALS; MP: 93 °C; FREELY SOL IN WATER, CHLOROFORM; SOL IN ALC, ACETONE, ETHYL ACETATE; PRACTICALLY INSOL IN ETHER, PETROLEUM ETHER, BENZENE /CITRATE/

물리화학적 성질

끓는 점
165 · 165-170 °C (1.33Pa)
밀도
1.048 · 1.048±0.06 g/cm3(Predicted)
굴절률
1.499 · 1.4990-1.5010
저장 조건
Refrigerator

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

유해성 정보

Regulatory InformationChemical: Cyclopentanecarboxylic acid, 1-phenyl-, 2-[2-(diethylamino)ethoxy]ethyl ester
Other Safety InformationIMAP assessments - Cyclopentanecarboxylic acid, 1-phenyl-, 2-[2-(diethylamino)ethoxy]ethyl ester: Environment tier I assessment

독성 정보

Human Toxicity ExcerptsDRYNESS OF MOUTH OR THROAT, FEELING OF TIGHTNESS IN CHEST, & SLIGHT DEGREE OF RESPIRATORY DEPRESSION...ALLERGIC DERMATITIS /ADVERSE EFFECT, ORAL/

안전 데이터

독성
LD50 oral in rat: 150mg/kg
HS 번호
2922509090
유해 물질 데이터
77-23-6(Hazardous Substances Data)

화학 및 산업

약리 정보

ATC Code · 2건

R - Respiratory system

QR - Respiratory system

Protein BindingNo pharmacokinetic data available.
Pharmacodynamics · 1건

Pentoxyverine induces an antitussive action. In animal studies, intraperitoneal administration of pentoxyverine inhibited citric-acid-induced cough in guinea-pigs _in vivo_. Some mice and rat studies suggest that pentoxyverine may also exert anticonvulsant activities without inducing a protective effect from NMDA-induced lethality. Protective effects against maximal electroshock-induced seizures in a dose-related fashion was also observed following either intraperitoneal or oral administration. In hERG-transfected cells, pentoxyverine inhibited the outward current of the hERG ion channel with half-maximal inhibition concentrations (IC50) of 3.0 µM. In rats receiving intrathecal administration, pentoxyverine exhibited dose-dependent spinal blockade with a more sensory-selective action over motor blockade. It induced a spinal blockade with a more sensory/nociceptive-selective action over motor blockade compared to lidocaine.

Mechanism of Action · 2건

While the mechanism of antitussive action of pentoxyverine is not fully understood, it is thought to be mediated via sigma-1 receptors expressed in the central nervous system. Pentoxyverine acts as an agonist at sigma receptors with the Ki of 75±28 nM, as demonstrated in a competitive binding assay. The function of sigma receptors on cough suppressant activities is unclear, however these receptors are highly expressed in the nucleus tractus solitarius (NTS) of the brainstem where the afferent fibres first synapse. NTS is located very close to the cough centre in the brainstem thus may function as a ‘gate' for the cough reflex and allow sigma-1 receptor agonists to modulate afferent activity prior to reaching the cough center. It is suggested that highly lipophilic sigma-1 agonists may penetrate the CNS following systemic administration. When administered as aerosols, sigma-1 receptor agonists may temporarily act in the periphery to modulate cough by acting activate sigma receptors expressed in the lungs. However there is limited evidence of peripheral localization of the sigma agonists following aerosol administration and the ruling out of systemic exposure. The local anesthesia action of pentoxyverine may occur through inhibition of voltage-gated Na(+) currents.

관련 반응

0건
반응 기록 만들기
아직 관련 반응이 없습니다

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
용해도
디클로로메탄(약간 용해됨), 메탄올(약간 용해됨)
산도 계수 (pKa)
9.69 · 9.69±0.25(Predicted)
물리적 상태
기름
색상
매우 어두운 빨간색에서 갈색까지 투명함
NIST
1 · 1-Cyclopentanecarboxylate, 2-(diethylaminoethoxy)ethyl-1-phenyl-(77-23-6)

NUMBER OF DRUGS ARE KNOWN TO REDUCE COUGH AS RESULT OF THEIR CENTRAL ACTIONS, ALTHOUGH EXACT MECHANISMS ARE STILL NOT ENTIRELY CLEAR. /NONOPIOID ANTITUSSIVES/

Biological Half-LifeThe half-life is 2.3 hours following oral dosing.
Metabolism/MetabolitesNo pharmacokinetic data available.
MeSH Pharmacological ClassificationAgents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally.
Absorption, Distribution and Excretion · 4건

In humans, maximum plasma concentrations are achieved 1.2 hours after oral dosing.

No pharmacokinetic data available.

No pharmacokinetic data available.

No pharmacokinetic data available.

용도 및 제조

Uses · 2건

MEDICATION

Use (kg; approx.) in Germany (2009): >1000

Methods of ManufacturingMORREN, BRITISH PATENT 753,799 (1956).
Formulations/PreparationsCARBETAPENTANE CITRATE /PRC: WITH CITRATE 1:1, TOCLASE & TUCLASE/. SYRUP, 7.25 MG/5 ML. SYRUP 7.25 MG, WITH TERPIN HYDRATE 16.7 MG, & CHLOROFORM 2.5 MG/5 ML (TOCLASE EXPECTORANT).
Use ClassificationPharmaceuticals

응용 분야

용도Carbetapentane is an antitussive anticonvulsant sigma site agonist.

상·하류 제품 정보

상류 원료

α-페닐시클로펜탄카르보닐클로라이드1-Phenylcyclopentanecarboxylic acidphenylacetonitrile3,4-메틸렌다이옥시페놀염화칼슘트라이클로로에틸렌다이에틸아민1,4-디브로모부탄1-Phenyl-1-cyclopentanecarbonitrile디에틸아미노에톡시에탄올나트륨아미드염화 티오닐